Papers: 17 Oct 2014 - 24 Oct 2014
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases.
A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.
Exclusive use of alternative medicine as a positive choice: a qualitative study of treatment assumptions among people with multiple sclerosis in denmark.
Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy.
Longitudinal Follow-up of a Cohort of Patients with Incidental Abnormal Magnetic Resonance Imaging Findings at Presentation and Their Risk of Developing Multiple Sclerosis.
Changes in Gross Grasp Strength and Fine Motor Skills in Adolescents with Pediatric Multiple Sclerosis.
Effect of a 2-week trial of functional electrical stimulation on gait function and quality of life in people with multiple sclerosis.
Intracerebroventricular injection of lipopolysaccharide increases gene expression of connexin32 gap junction in rat hippocampus.
Central and Peripheral Nervous System Demyelination Following Mycoplasma Pneumonia Infection With Review of Literature.
Correction: deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption.
Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach.
Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10.
Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literature.
Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.
Long-term effectiveness of combined cognitive-behavioral and neuropsychological intervention in a case of multiple sclerosis.
Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy.
Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis.
Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammation.
Coordinated Gene Expression of Neuroinflammatory and Cell Signaling Markers in Dorsolateral Prefrontal Cortex during Human Brain Development and Aging.
MS14 Down-regulates Lipocalin2 Expression in Spinal Cord Tissue in an Animal Model of Multiple Sclerosis in female C57BL/6.
Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis.
Expression of a Second Ecto-5'-Nucleotidase Variant Besides the Usual Protein in Symptomatic Phase of Experimental Autoimmune Encephalomyelitis.
Circulating Levels of Interleukin-35 in Patients with Multiple Sclerosis: Evaluation of the Influences of FOXP3 Gene Polymorphism and Treatment Program.
Effects of Coenzyme Q10 on the ratio of TH1/TH2 in Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis in C57BL/6.
Motor programme activating therapy influences adaptive brain functions in multiple sclerosis: clinical and MRI study.
Dietary Sutherlandia and Elderberry Mitigate Cerebral Ischemia-Induced Neuronal Damage and Attenuate p47phox and Phospho-ERK1/2 Expression in Microglial Cells.
Anti-Inflammatory Potential of Newly Synthesized 4-[(Butylsulfinyl)methyl]-1,2-benzenediol in Lipopolysaccharide-Stimulated BV2 Microglia.
Exacerbation of Autoimmune Neuro-Inflammation in Mice Cured from Blood-Stage Plasmodium berghei Infection.
Sample size estimation for negative binomial regression comparing rates of recurrent events with unequal follow-up time.
Application of three focused cluster detection methods to study geographic variation in the incidence of multiple sclerosis in manitoba, Canada.
Patient with Neuromyelitis Optica Spectrum Disorder Combined with Sjögren's Syndrome Relapse Free Following Tacrolimus Treatment.
JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level.
Contingent negative variation is associated with cognitive dysfunction and secondary progressive disease course in multiple sclerosis.
Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient Survey.